Stay updated on Efficacy of Bemcentinib in Myelodysplastic Syndromes Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Bemcentinib in Myelodysplastic Syndromes Clinical Trial page.

Latest updates to the Efficacy of Bemcentinib in Myelodysplastic Syndromes Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page shows a new revision note (v3.4.2). A funding/status notice and the earlier revision (v3.4.1) have been removed.SummaryDifference0.4%

- Check20 days agoChange DetectedA site-wide status notice about potential delays in updates due to government funding and the NIH Clinical Center's operating status was added, and a new revision tag (v3.4.1) was introduced. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedThe page adds a glossary display option and updates several labels for capitalization (Met vs met and Data vs data) along with the revision tag to v3.4.0.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page shows a small version update: Revision: v3.3.4 replaces v3.3.3 and does not modify study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded locations Nantes Cedex 1 and Paris 7 to the study locations and updated the revision from v3.3.2 to v3.3.3; the HHS Vulnerability Disclosure link was removed.SummaryDifference0.3%

- Check91 days agoChange DetectedRevision: v3.3.2 added and v3.2.0 removed, reflecting internal document version updates without altering study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Efficacy of Bemcentinib in Myelodysplastic Syndromes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Bemcentinib in Myelodysplastic Syndromes Clinical Trial page.